<code id='DC80D09852'></code><style id='DC80D09852'></style>
    • <acronym id='DC80D09852'></acronym>
      <center id='DC80D09852'><center id='DC80D09852'><tfoot id='DC80D09852'></tfoot></center><abbr id='DC80D09852'><dir id='DC80D09852'><tfoot id='DC80D09852'></tfoot><noframes id='DC80D09852'>

    • <optgroup id='DC80D09852'><strike id='DC80D09852'><sup id='DC80D09852'></sup></strike><code id='DC80D09852'></code></optgroup>
        1. <b id='DC80D09852'><label id='DC80D09852'><select id='DC80D09852'><dt id='DC80D09852'><span id='DC80D09852'></span></dt></select></label></b><u id='DC80D09852'></u>
          <i id='DC80D09852'><strike id='DC80D09852'><tt id='DC80D09852'><pre id='DC80D09852'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:12776
          Beth Israel Deaconess Medical Center in Boston
          David L. Ryan/The Boston Globe

          Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

          While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

          advertisement

          Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Eli Lilly reports tirzepatide MASH success during Q4 earnings
          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk